Valuation CSPC Pharmaceutical Group Limited

Stocks

Market Closed - Hong Kong S.E. Other stock markets 09:08:04 27/07/2026 BST			5-day change	1st Jan Change
8.300 ^HKD	-2.92%		+2.47%	-1.54%

07-24	CSPC Pharmaceutical Group Limited Announces Marketing Approval For Paliperidone Palmitate Injection	CI
07-22	CSPC Pharmaceutical Group Limited Initiates Phase II Clinical Trial of Sys6026 Injection for HPV Type 16 or 18 Related Cervical High Grade Squamous Intraepithelial Lesion in China	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	100,932	97,707	86,022	55,169	96,380	94,894	-	-
Change	-	-3.19%	-11.96%	-35.87%	74.7%	-1.54%	-	-
Enterprise Value (EV) ¹	89,633	86,241	72,284	46,931	86,710	84,253	81,144	77,571
Change	-	-3.79%	-16.18%	-35.07%	84.76%	-2.83%	-3.69%	-4.4%
P/E	14.7x	14.1x	13.5x	12.1x	21.8x	11.7x	13.5x	12.4x
PBR	3.17x	2.86x	2.39x	1.62x	2.56x	2.21x	2.02x	1.84x
PEG	-	14.13x	-1.73x	-0.5x	-9.88x	0.1x	-1x	1.39x
Capitalization / Revenue	2.94x	2.77x	2.52x	1.78x	3.26x	2.67x	2.7x	2.53x
EV / Revenue	2.61x	2.44x	2.12x	1.51x	2.94x	2.37x	2.31x	2.07x
EV / EBITDA	9.5x	9.43x	8.39x	6.22x	12.1x	6.69x	8.21x	7.4x
EV / EBIT	10.7x	10.8x	9.77x	7.68x	15.6x	9.27x	10.6x	9.52x
EV / FCF	23.7x	14.1x	26.2x	17.5x	19.5x	11.4x	11.6x	8.28x
FCF Yield	4.22%	7.11%	3.82%	5.71%	5.12%	8.75%	8.6%	12.1%
Dividend per Share ²	0.18	0.21	0.28	0.26	0.29	0.3634	0.3684	0.3828
Rate of return	2.13%	2.56%	3.86%	5.44%	3.44%	4.38%	4.44%	4.61%
EPS ²	0.5773	0.5831	0.5376	0.3946	0.3859	0.7121	0.6168	0.6719
Distribution rate	31.2%	36%	52.1%	65.9%	75.2%	51%	59.7%	57%
Net sales ¹	34,309	35,292	34,175	31,046	29,533	35,574	35,132	37,494
EBITDA ¹	9,431	9,148	8,615	7,547	7,168	12,599	9,887	10,478
EBIT ¹	8,366	7,952	7,400	6,113	5,564	9,084	7,672	8,152
Net income ¹	6,901	6,949	6,382	4,632	4,409	7,864	6,920	7,536
Net Debt ¹	-11,298	-11,467	-13,738	-8,238	-9,670	-10,641	-13,750	-17,323
Reference price ²	8.470	8.200	7.260	4.780	8.430	8.300	8.300	8.300
Nbr of stocks (in thousands)	11,916,370	11,915,520	11,848,756	11,541,665	11,433,025	11,433,025	-	-
Announcement Date	22/03/22	22/03/23	20/03/24	28/03/25	25/03/26	-	-	-

¹HKD in Million²HKD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
CSPC PHARMACEUTICAL GROUP LIMITED	12.01x	2.45x	6.91x	4.25%	12.46B
ELI LILLY AND COMPANY	35.93x	12.68x	26.75x	0.57%	1,067B
JOHNSON & JOHNSON	28.24x	6.45x	17.87x	2.04%	635B
ABBVIE INC.	32.64x	7.65x	15.73x	2.65%	458B
ROCHE HOLDING AG	19.22x	4.69x	11.59x	2.82%	347B
NOVARTIS AG	21.56x	5.71x	14.24x	2.81%	295B
ASTRAZENECA PLC	21.1x	4.45x	12.31x	1.98%	262B
NOVO NORDISK A/S	14.14x	5.26x	10.84x	3.54%	216B
AMGEN INC.	24.66x	6.48x	11.43x	2.68%	203B
GILEAD SCIENCES, INC.	-46.58x	5.59x	30.88x	2.55%	161B
Average	16.29x	6.14x	15.85x	2.59%	365.6B
Weighted average by Cap.	24.75x	7.93x	18.66x	1.97%